DK270983A - 1-aryloxy-2,3,4,5-tetrahydro-3-benzazepiner, en fremgangsmaade til fremstilling deraf og deres anvendelse - Google Patents

1-aryloxy-2,3,4,5-tetrahydro-3-benzazepiner, en fremgangsmaade til fremstilling deraf og deres anvendelse Download PDF

Info

Publication number
DK270983A
DK270983A DK270983A DK270983A DK270983A DK 270983 A DK270983 A DK 270983A DK 270983 A DK270983 A DK 270983A DK 270983 A DK270983 A DK 270983A DK 270983 A DK270983 A DK 270983A
Authority
DK
Denmark
Prior art keywords
sub
hydrogen
lower alkyl
benzazepines
tetrahydro
Prior art date
Application number
DK270983A
Other languages
Danish (da)
English (en)
Other versions
DK270983D0 (da
Inventor
Richard Charles Effland
Joseph Thomas Klein
Larry Davis
Original Assignee
Hoechst Roussel Pharma
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoechst Roussel Pharma filed Critical Hoechst Roussel Pharma
Publication of DK270983D0 publication Critical patent/DK270983D0/da
Publication of DK270983A publication Critical patent/DK270983A/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D223/00—Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom
    • C07D223/14—Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom condensed with carbocyclic rings or ring systems
    • C07D223/16—Benzazepines; Hydrogenated benzazepines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/26—Psychostimulants, e.g. nicotine, cocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Psychiatry (AREA)
  • Pain & Pain Management (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Other In-Based Heterocyclic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
DK270983A 1982-06-14 1983-06-13 1-aryloxy-2,3,4,5-tetrahydro-3-benzazepiner, en fremgangsmaade til fremstilling deraf og deres anvendelse DK270983A (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US06/387,916 US4988690A (en) 1982-06-14 1982-06-14 1-aryloxy-2,3,4,5-tetrahydro-3-benzazepines and anti-depressant use thereof

Publications (2)

Publication Number Publication Date
DK270983D0 DK270983D0 (da) 1983-06-13
DK270983A true DK270983A (da) 1983-12-15

Family

ID=23531838

Family Applications (1)

Application Number Title Priority Date Filing Date
DK270983A DK270983A (da) 1982-06-14 1983-06-13 1-aryloxy-2,3,4,5-tetrahydro-3-benzazepiner, en fremgangsmaade til fremstilling deraf og deres anvendelse

Country Status (17)

Country Link
US (1) US4988690A (mo)
EP (1) EP0096838B1 (mo)
JP (1) JPS595165A (mo)
KR (1) KR900001214B1 (mo)
AT (1) ATE26263T1 (mo)
AU (1) AU570920B2 (mo)
CA (1) CA1214460A (mo)
DE (1) DE3370621D1 (mo)
DK (1) DK270983A (mo)
ES (1) ES523191A0 (mo)
FI (1) FI78473C (mo)
GR (1) GR78291B (mo)
HU (1) HU190902B (mo)
IE (1) IE55404B1 (mo)
IL (1) IL68964A (mo)
PT (1) PT76864B (mo)
ZA (1) ZA834309B (mo)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ZA882080B (en) * 1987-03-27 1989-04-26 Schering Corp Substituted benzazepines,their preparation and pharmaceutical compositions containing them
US5015639A (en) * 1987-03-27 1991-05-14 Schering Corporation Substituted benzazepines, their preparation and pharmaceutical compositions containing them
CA1327795C (en) * 1987-08-14 1994-03-15 Jules Freedman Antidepressants which are aryloxy inadanamines
US5202319A (en) * 1991-09-23 1993-04-13 Hoechst-Roussel Pharmaceuticals Inc. Substituted 3-amino-2,3,4,5-tetrahydro-1-aryloxy-3-benzazepines
US5639482A (en) * 1993-11-10 1997-06-17 Crary; Ely J. Composition for control and prevention of diabetic retinopathy
WO2002044144A2 (en) * 2000-11-30 2002-06-06 Advanced Research And Technology Institute, Inc. Nucleophilic approach for preparing radiolabeled imaging agents and associated compounds
US6953787B2 (en) * 2002-04-12 2005-10-11 Arena Pharmaceuticals, Inc. 5HT2C receptor modulators
MXPA05013366A (es) * 2003-06-17 2006-04-05 Arena Pharm Inc Derivados de benzazepina utiles para el tratamiento de enfermedades asociadas con el receptor 5ht2c.
ES2571220T3 (es) 2003-06-17 2016-05-24 Arena Pharm Inc Clorhidrato de 8-cloro-1-metil-2,3,4,5-tetrahidro-1H-3-benzazepina
WO2005042490A1 (en) * 2003-10-22 2005-05-12 Arena Pharmaceuticals, Inc. Benzazepine derivatives and methods of prophylaxis or treatment of 5ht2c receptor associated diseases
WO2005042491A1 (en) * 2003-10-22 2005-05-12 Arena Pharmaceuticals, Inc. Benzazepine derivatives and methods of prophylaxis or treatment of 5ht2c receptor associated diseases
EA017894B1 (ru) 2004-12-21 2013-04-30 Арена Фармасьютикалз, Инк. Кристаллические формы гидрохлорида (r)-8-хлор-1-метил-2,3,4,5-тетрагидро-1h-3-бензазепина
NZ555482A (en) 2004-12-23 2011-01-28 Arena Pharm Inc Compositions comprising a 5HT2C receptor modulator and 2-methylamphetamine and methods of use
CA2646044A1 (en) 2006-04-03 2007-10-25 Arena Pharmaceuticals, Inc. Processes for the preparation of 8-chloro-1-methyl-2,3,4,5-tetrahydro-1h-3-benzazepine and intermediates related thereto
US8299241B2 (en) * 2006-12-05 2012-10-30 Arena Pharmaceuticals, Inc. Processes for preparing (R)-8-chloro-1-methyl-2,3,4,5-tetrahydro-1H-3-benzazepine and intermediates thereof
EA017308B1 (ru) 2007-05-10 2012-11-30 Олбани Молекьюлар Рисерч, Инк. Арилокси- и гетероарилоксизамещенные тетрагидробензазепины и их применение для блокировки обратного захвата норэпинефрина, допамина и серотонина
US8822727B2 (en) 2008-03-04 2014-09-02 Arena Pharmaceuticals, Inc. Processes for the preparation of intermediates related to the 5-HT2C agonist (R)-8-chloro-1-methyl-2,3,4,5-tetrahydro-1H-3-benzazepine
CN102648170A (zh) 2009-06-18 2012-08-22 艾尼纳制药公司 制备5-ht2c受体激动剂的方法
US9045431B2 (en) 2010-06-02 2015-06-02 Arena Pharmaceuticals, Inc. Processes for the preparation of 5-HT2C receptor agonists
EP2611782A1 (en) 2010-09-01 2013-07-10 Arena Pharmaceuticals, Inc. Salts of lorcaserin with optically active acids
EP2939677A1 (en) 2010-09-01 2015-11-04 Arena Pharmaceuticals, Inc. Administration of lorcaserin to indviduals with renal impairment
WO2012030927A2 (en) 2010-09-01 2012-03-08 Arena Pharmaceuticals, Inc. Modified-release dosage forms of 5-ht2c agonists useful for weight management
JP2013536859A (ja) 2010-09-01 2013-09-26 アリーナ ファーマシューティカルズ， インコーポレイテッド ５−ｈｔ２ｃアゴニストの非吸湿性塩
UY34436A (es) 2012-10-09 2014-07-31 Arena Pharm Inc Metodo de control del peso

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5233687A (en) * 1975-09-11 1977-03-14 Shionogi & Co Ltd Process for preparation of 1,5-dihydro-2h-1,4-benzodiazepine-2-on deri vatives
JPS5481290A (en) * 1977-11-17 1979-06-28 Smithkline Corp Benzazepin compound

Also Published As

Publication number Publication date
IL68964A0 (en) 1983-10-31
US4988690A (en) 1991-01-29
HU190902B (en) 1986-12-28
GR78291B (mo) 1984-09-26
JPS595165A (ja) 1984-01-12
CA1214460A (en) 1986-11-25
JPH0365342B2 (mo) 1991-10-11
PT76864A (en) 1983-07-01
EP0096838B1 (en) 1987-04-01
FI832092L (fi) 1983-12-15
PT76864B (en) 1986-02-27
ATE26263T1 (de) 1987-04-15
IL68964A (en) 1988-03-31
ES8503666A1 (es) 1985-03-01
FI78473B (fi) 1989-04-28
FI78473C (fi) 1989-08-10
IE831384L (en) 1983-12-14
AU1576483A (en) 1983-12-22
ZA834309B (en) 1984-03-28
DK270983D0 (da) 1983-06-13
KR840005103A (ko) 1984-11-03
DE3370621D1 (en) 1987-05-07
ES523191A0 (es) 1985-03-01
IE55404B1 (en) 1990-09-12
EP0096838A1 (en) 1983-12-28
AU570920B2 (en) 1988-03-31
KR900001214B1 (ko) 1990-02-28
FI832092A0 (fi) 1983-06-10

Similar Documents

Publication Publication Date Title
DK270983A (da) 1-aryloxy-2,3,4,5-tetrahydro-3-benzazepiner, en fremgangsmaade til fremstilling deraf og deres anvendelse
MY109937A (en) Substituted azoles, processes for the preparation thereof, agents containing these, and the use thereof.
EP0202577A3 (en) N(acyldipeptidyl)-aminoglycols
ATE17249T1 (de) 9-(2-(3-indolyl)aethyl)-1-oxa-4,9diazaspiro(5.5)undecan-3-one.
EP0254327A3 (en) N-n-disubstituted-omega-(2-amino-3-(carbonylmethyl)-3,4-dihydroquinazolinyl) oxyalkylamides and related compounds
ES8401961A1 (es) Procedimiento para la preparacion de nuevas n-(4-indolil-piperidino-alcohil-bencimidazolonas sustituidas.
ES8609204A1 (es) Procedimiento de preparar derivados aminicos
DK286982A (da) Fremgangsmaade til fremstilling af pyrimidonderivater
ES8601201A1 (es) Procedimiento para preparar derivados de imidazolina
DK322588A (da) Cycloalkylamider af 6-substituerede (8beta)-1-alkylergoliner og fremgangsmaade til fremstilling af saadanne forbindelser
ES8308543A1 (es) "procedimiento para la preparacion de nuevas 2-fenil-2-(piridiloxi)-etilaminas sustituidas".
EP0251574A3 (en) Antifungal derivatives of n-(6,6-dimethyl-2-hepten-4-ynyl)-1-naphthalenemethanamine and method of using same
DK440987A (da) Thyroninderivater, deres fremstilling og anvendelse
ES8504180A1 (es) Procedimiento para preparar nuevos derivados de piperidina
HUT43568A (en) Process for preparing novel 2-pyridiyl-acetic acid derivatives and pharmaceutics comprising the same
GR880100112A (en) Method of preparation of new acetamide deravatives of dihydro-2,3 phenyl-3 benzophouranone-2
GR81771B (mo)
DK60793D0 (da) Kemiske forbindelser, deres fremstilling og anvendelse
DE3662039D1 (de) Novel diamine derivatives
JPS5636414A (en) Anticonvulsant agent containing omega-aminoalkoxystilbene or its acid addition salt as active constituent
ES8609300A1 (es) Un procedimiento para la preparacion de nuevas amonicas derivadas de 1,2,3,4,4a,10a-hexahidrodibenzo(b,e)(1,4)-dioxin 4,ol.

Legal Events

Date Code Title Description
AHS Application shelved for other reasons than non-payment